Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Corero secures large contract renewal and expansion

(Sharecast News) - Corero Network Security announced a substantial contract renewal and expansion with a prominent US software-as-a-service (SaaS) provider on Wednesday, marking one of its most significant transactions to date. The AIM-traded firm said the contract, valued at over $2m over three years, would see Corero enhancing the customer's existing distributed denial of service (DDoS) protection infrastructure to support its ongoing international expansion.

It said the contract's expansion substantially fortified the customer's DDoS protection infrastructure, ensuring the security and uninterrupted service availability of the SaaS provider's operations worldwide.

"This significant contract renewal and expansion is testament to the trust and confidence that leading global companies continue to place in Corero's DDoS protection solutions," said chief executive officer Carl Herberger.

"Not only does the contract reflect our capability to meet the sophisticated needs of our customers, but it also demonstrates that we are well positioned to capitalise on potential upsell opportunities with existing clients who have already benefited significantly from our services.

"We are committed to providing cutting-edge, reliable DDoS protection solutions to support our customers' growth and operational security and will continue to explore new business and mandate expansion opportunities as we aim to both broaden and strengthen our client portfolio."

At 1325 BST, shares in Corero Network Security were up 14.11% at 10.27p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Hikma boosts injectables business with Xellia assets acquisition
(Sharecast News) - Hikma Pharmaceuticals said on Monday that it has agreed to buy parts of Xellia Pharmaceuticals, a Copenhagen-based specialty company focusing on providing anti-infective treatments and other critical care therapies, for up to $185m.
Ascential on track to hit targets this year
(Sharecast News) - Publishing, events and B2B consultancy group Ascential has said that trading is in line with expectations for the full year, helped by strong growth in marketing and fintech operations.
AstraZeneca's Imfinzi gets US approval for endometrial cancer patients
(Sharecast News) - AstraZeneca said its Imfinzi cancer treatment had been approved in the US as treatment for adult patients with primary advanced or recurrent endometrial cancer.
British Land CFO to join Kingfisher
(Sharecast News) - B&Q owner Kingfisher said it had appointed British Land chief financial officer Bhavesh Mistry to the same role at the home improvement company.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.